Brinzolamide
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 470 publications
Chitosan modulated niosomes for improved ocular delivery of brinzolamide.
Journal: Pharmaceutical development and technology
Published: October 07, 2026
Topical Carbonic Anhydrase Inhibitors in Macular Edema: A Systematic Review.
Journal: Cureus
Published: September 20, 2026
Soluble ocular insert of brinzolamide and timolol maleate: in-vitro, ex-vivo and in-vivo characterization.
Journal: Therapeutic delivery
Published: September 11, 2026
Abstract: Recognizing Early Signs of Primary Congenital Glaucoma in Infancy.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association
Published: July 29, 2026
Solid-state effects of Brinzolamide on sustained intravitreal release from hot-melt extruded PLGA implants.
Journal: International journal of pharmaceutics
Published: June 02, 2026
Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.
Journal: International journal of pharmaceutics
Published: April 27, 2026
Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.
Journal: International journal of pharmaceutics
Published: April 27, 2026
Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations.
Journal: Ophthalmic genetics
Published: March 31, 2026
Ectropion uveae in a pediatric patient with refractory NF1-associated glaucoma: a 4-year case report.
Journal: Frontiers in medicine
Published: March 19, 2026
Last Updated: 11/08/2026